Sab Bio

Sab Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D)

Company Details

Employees
62
Address
Miami, Fl , Us
Phone
(605)679-6980
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Brookings.
HQ
Miami, FL
Looking for a particular Sab Bio employee's phone or email?

Sab Bio Questions

News

SAB BIO Highlights Data in Multiple Presentations at EASD - GlobeNewswire

SAB BIO Highlights Data in Multiple Presentations at EASD GlobeNewswire

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Yahoo Finance

SAB Biotherapeutics Board Members Resign in Agreement - TipRanks

SAB Biotherapeutics Board Members Resign in Agreement TipRanks

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates - GlobeNewswire

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates GlobeNewswire

SAB BIO Announces Oversubscribed $175 Million Private Placement - GlobeNewswire

SAB BIO Announces Oversubscribed $175 Million Private Placement GlobeNewswire

COVID antibodies developed in South Dakota cattle study - Beef Magazine

COVID antibodies developed in South Dakota cattle study Beef Magazine

SAb Biotherapeutics, Inc. : Quotes, Address, Contact - News-Medical

SAb Biotherapeutics, Inc. : Quotes, Address, Contact News-Medical

SAB Biotherapeutics announces up to $130M in funding for diabetes treatment - SiouxFalls.Business

SAB Biotherapeutics announces up to $130M in funding for diabetes treatment SiouxFalls.Business

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates - GlobeNewswire

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates GlobeNewswire

Moove over IPO: SAB Biotherapeutics to milk the stock market via SPAC - Fierce Biotech

Moove over IPO: SAB Biotherapeutics to milk the stock market via SPAC Fierce Biotech

Photos: SAB Biotherapeutics expands research laboratory, gets new headquarters - Argus Leader

Photos: SAB Biotherapeutics expands research laboratory, gets new headquarters Argus Leader

SAB Biotherapeutics (SABS) Stock Price, News & Analysis - MarketBeat

SAB Biotherapeutics (SABS) Stock Price, News & Analysis MarketBeat

SAB BIO Reports Full Year 2024 Operating and Financial Results - GlobeNewswire

SAB BIO Reports Full Year 2024 Operating and Financial Results GlobeNewswire

Human trials to commence using SARS-CoV-2 antibodies from cow's blood - News-Medical

Human trials to commence using SARS-CoV-2 antibodies from cow's blood News-Medical

SAB Biotherapeutics' Canton operations marks next stage of biopharm business growth - Argus Leader

SAB Biotherapeutics' Canton operations marks next stage of biopharm business growth Argus Leader

SABS News Today | Why did SAB Biotherapeutics stock go up today? - MarketBeat

SABS News Today | Why did SAB Biotherapeutics stock go up today? MarketBeat

SAB BIO Announces Positive Topline Phase 1 Clinical Results - GlobeNewswire

SAB BIO Announces Positive Topline Phase 1 Clinical Results GlobeNewswire

SAb Biotherapeutics Rebrands as SAB BIO - GlobeNewswire

SAb Biotherapeutics Rebrands as SAB BIO GlobeNewswire

Top Sab Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant